查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1225066

即时护理 (POC) 脂质检测市场：按产品类型、应用、最终用户分类：2021-2031 年全球机会分析和行业预测

Point of Care lipid Test Market By Product Type, By Application, By End User : Global Opportunity Analysis and Industry Forecast, 2021-2031
出版日期: | 出版商: Allied Market Research | 英文 | 商品交期: 2-3个工作天内

价格

2021 年全球床旁 (POC) 血脂检测市场将达到 2.8486 亿美元，2022 年至 2031 年的复合年增长率为 4.1%，预计 2031 年将达到 4.2658 亿美元

即时检验 (POC) 测试是一种医学测试，可帮助识别人体内的慢性并发症。 简而言之，与其他传统诊断方法相比，床旁 (POC) 检测有助于快速诊断问题并缩短住院时间。 床旁 (POC) 诊断有助于在几分钟内提供实时结果。 进行即时护理 (POC) 脂质测试以确定细胞内脂质的功能情况。 胆固醇水平升高会改变脂质在体内的作用方式，导致心脏病发作和冠状动脉疾病等严重疾病。

由于全球治疗意识的提高，预计在预测期内，床旁 (POC) 脂质检测市场将出现显着的市场增长。 此外，心血管疾病、肥胖症和其他疾病患病率的增加进一步推动了市场增长。 然而，与护理点 (POC) 脂质检测的研究和开发相关的成本上升预计会阻碍市场增长。 另一方面，医疗保健行业对基础设施和技术进步的大量投资需求预计将为即时 (POC) 脂质检测市场提供重要的增长机会。

床旁 (POC) 脂质检测市场根据产品类型、应用、最终用户和地区进行细分。 按产品划分，市场分为设备和消耗品。 根据应用，市场分为内源性高脂血症、混合性高脂血症、家族性高胆固醇血症等。 在最终用户的基础上，它分为医院和诊所、诊断实验室和其他。

内容

第1章介绍

第 2 章执行摘要

第 3 章市场概述

  • 市场定义和范围
  • 主要发现
    • 主要投资领域
  • 波特的五力分析
  • 市场动态
    • 司机
      • 肥胖人口激增
      • 政府加大力度促进健康的生活方式
      • 心血管疾病和糖尿病的患病率增加
    • 阻碍因素
      • 产品开发成本高
    • 机会
      • 新兴经济体的增长潜力
  • 分析 COVID-19 对市场的影响

第 4 章护理点 (POC) 脂质检测市场：按产品类型分类

  • 概览
    • 市场规模和预测
  • 设备
    • 主要市场趋势、增长因素和机遇
    • 市场规模和预测：按地区
    • 市场份额分析：按国家/地区分类
  • 消耗品
    • 主要市场趋势、增长因素和机遇
    • 市场规模和预测：按地区
    • 市场份额分析：按国家/地区分类

第 5 章护理点 (POC) 脂质检测市场：按应用

  • 概览
    • 市场规模和预测
  • 内在性高脂血症
    • 主要市场趋势、增长因素和机遇
    • 市场规模和预测：按地区
    • 市场份额分析：按国家/地区分类
  • 复杂性高脂血症
    • 主要市场趋势、增长因素和机遇
    • 市场规模和预测：按地区
    • 市场份额分析：按国家/地区分类
  • 家族性高胆固醇血症
    • 主要市场趋势、增长因素和机遇
    • 市场规模和预测：按地区
    • 市场份额分析：按国家/地区分类
  • 其他
    • 主要市场趋势、增长因素和机遇
    • 市场规模和预测：按地区
    • 市场份额分析：按国家/地区分类

第 6 章护理点 (POC) 脂质检测市场：按最终用户分类

  • 概览
    • 市场规模和预测
  • 医院和诊所
    • 主要市场趋势、增长因素和机遇
    • 市场规模和预测：按地区
    • 市场份额分析：按国家/地区分类
  • 诊断实验室
    • 主要市场趋势、增长因素和机遇
    • 市场规模和预测：按地区
    • 市场份额分析：按国家/地区分类
  • 其他
    • 主要市场趋势、增长因素和机遇
    • 市场规模和预测：按地区
    • 市场份额分析：按国家/地区分类

第 7 章。护理点 (POC) 脂质检测市场：按地区

  • 概览
    • 市场规模和预测
  • 北美
    • 主要趋势和机会
    • 北美市场规模和预测：按产品类型
    • 北美市场规模和预测：按应用
    • 北美市场规模和预测：按最终用户分类
    • 北美市场规模和预测：按国家/地区分类
      • 美国
      • 主要市场趋势、增长因素和机遇
      • 市场规模和预测：按产品类型
      • 市场规模和预测：按应用
      • 市场规模和预测：按最终用户分类
      • 加拿大
      • 主要市场趋势、增长因素和机遇
      • 市场规模和预测：按产品类型
      • 市场规模和预测：按应用
      • 市场规模和预测：按最终用户分类
      • 墨西哥
      • 主要市场趋势、增长因素和机遇
      • 市场规模和预测：按产品类型
      • 市场规模和预测：按应用
      • 市场规模和预测：按最终用户分类
  • 欧洲
    • 主要趋势和机会
    • 欧洲市场规模和预测：按产品类型
    • 欧洲市场规模和预测：按应用分类
    • 欧洲市场规模和预测：按最终用户分类
    • 欧洲市场规模和预测：按国家/地区分类
      • 德国
      • 主要市场趋势、增长因素和机遇
      • 德国市场规模和预测：按产品类型
      • 市场规模和预测：按应用
      • 市场规模和预测：按最终用户分类
      • 法国
      • 主要市场趋势、增长因素和机遇
      • 市场规模和预测：按产品类型
      • 市场规模和预测：按应用
      • 市场规模和预测：按最终用户分类
      • 英国
      • 主要市场趋势、增长因素和机遇
      • 市场规模和预测：按产品类型
      • 市场规模和预测：按应用
      • 市场规模和预测：按最终用户分类
      • 意大利
      • 主要市场趋势、增长因素和机遇
      • 市场规模和预测：按产品类型
      • 市场规模和预测：按应用
      • 市场规模和预测：按最终用户分类
      • 西班牙
      • 主要市场趋势、增长因素和机遇
      • 市场规模和预测：按产品类型
      • 市场规模和预测：按应用
      • 市场规模和预测：按最终用户分类
      • 其他欧洲
      • 主要市场趋势、增长因素和机遇
      • 市场规模和预测：按产品类型
      • 市场规模和预测：按应用
      • 市场规模和预测：按最终用户分类
  • 亚太地区
    • 主要趋势和机会
    • 亚太地区市场规模和按产品类型预测
    • 亚太地区的市场规模和预测：按应用分类
    • 亚太市场规模和预测：按最终用户分类
    • 亚太地区的市场规模和预测：按国家/地区分类
      • 日本
      • 主要市场趋势、增长因素和机遇
      • 亚太地区市场规模和按产品类型预测
      • 亚太地区的市场规模和预测：按应用分类
      • 市场规模和预测：按最终用户分类
      • 中国
      • 主要市场趋势、增长因素和机遇
      • 市场规模和预测：按产品类型
      • 市场规模和预测：按应用
      • 市场规模和预测：按最终用户分类
      • 印度
      • 主要市场趋势、增长因素和机遇
      • 市场规模和预测：按产品类型
      • 市场规模和预测：按应用
      • 市场规模和预测：按最终用户分类
      • 澳大利亚
      • 主要市场趋势、增长因素和机遇
      • 市场规模和预测：按产品类型
      • 市场规模和预测：按应用
      • 市场规模和预测：按最终用户分类
      • 韩国
      • 主要市场趋势、增长因素和机遇
      • 市场规模和预测：按产品类型
      • 市场规模和预测：按应用
      • 市场规模和预测：按最终用户分类
      • 其他亚太地区
      • 主要市场趋势、增长因素和机遇
      • 市场规模和预测：按产品类型
      • 市场规模和预测：按应用
      • 市场规模和预测：按最终用户分类
  • 拉丁美洲/中东/非洲
    • 主要趋势和机会
    • LAMEA 市场规模和预测：按产品类型
    • LAMEA 市场规模和预测：按应用分类
    • LAMEA 市场规模和预测：按最终用户分类
    • LAMEA 市场规模和预测：按国家/地区分类
      • 巴西
      • 主要市场趋势、增长因素和机遇
      • 市场规模和预测：按产品类型
      • 市场规模和预测：按应用
      • 市场规模和预测：按最终用户分类
      • 沙特阿拉伯
      • 主要市场趋势、增长因素和机遇
      • 市场规模和预测：按产品类型
      • 市场规模和预测：按应用
      • 市场规模和预测：按最终用户分类
      • 南非
      • 主要市场趋势、增长因素和机遇
      • 市场规模和预测：按产品类型
      • 市场规模和预测：按应用
      • 市场规模和预测：按最终用户分类
      • LAMEA 的其余部分
      • 主要市场趋势、增长因素和机遇
      • 市场规模和预测：按产品类型
      • 市场规模和预测：按应用
      • 市场规模和预测：按最终用户分类

第8章竞争格局

  • 介绍
  • 关键成功策略
  • 排名前 10 位的玩家产品映射
  • 比赛仪表板
  • 竞争热图
  • 定位顶级公司，2021 年

第9章公司简介

  • Abbott Laboratories
  • Callegari
  • F. Hoffmann-La Roche Ltd.
  • Menarini Group
  • Mico Bio Med
  • Nova Biomedical Corporation
  • SD Biosensor, Inc.
  • Sinocare Inc.
  • VivaChek Biotech（Hangzhou）Co.,Ltd
  • Zoetis Inc.
Product Code: A14046

The global point of care lipid test market accounted for $284.86  million in 2021 and is expected to reach $426.58  million by 2031, registering a CAGR of 4.1% from 2022 to 2031.

Point of care (POC) test is one of the medical tests that assist in identifying chronic complications inside the human body. This means that, in contrast to other traditional diagnostic procedures, point-of-care testing assists in quickly diagnosing issues and shorten hospital stays. The point-of-care diagnostics assists in delivering real-time results in a matter of minutes. Point of care (POC) lipid test is performed to determine how well the lipids in the cells are working. When cholesterol levels rise, it changes how lipids work in the body and, as a result, can cause serious ailments such as heart attacks and coronary artery disease. 

It is estimated that point of care lipid test market is expected to experience significant market growth during the forecast period owing to the rise in awareness on medical therapeutics on a global scale. In addition, increase in number of patients suffering from cardiovascular diseases, obesity, and other diseases  further propel  the growth of the market. However, rising cost associated with R&D of point of care lipid test is expected to impede the market growth. . In contrast, big investments in healthcare sector infrastructure and need for advancement in technology are anticipated to provide significant growth opportunities for the point of care lipid test market.

The Point of care lipid test market is segmented on the basis of product type, application, end user, and region. Depending on product, the market is classified into devices and consumables. On the basis of application, the market is divided into endogenous hyperlipidemia, combined hyperlipidemia , familial hypercholesterolemia, and others. By end user, the market is classified into hospitals & Clinics, diagnostics laboratories , and others. 

Region wise, the market is analyzed across North America (the U.S., Canada, and Mexico), Europe (Germany, France, the UK, Italy, Spain, and rest of Europe), Asia-Pacific (Japan, China, Australia, India, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, South Africa, Saudi Arabia, and rest of LAMEA).

The report provides a comprehensive analysis of the key players that operate in the global point of care lipid test market. The key companies profiled in the report include Abbott Laboratories, Callegari, F. Hoffmann-La Roche Ltd., Menarini Group, Mico Bio Med, Nova Biomedical Corporation, SD biosensor, inc., Sinocare Inc., VivaChek Biotech (Hangzhou) Co.,Ltd, and Zoetis Inc.

Key Benefits For Stakeholders

  • This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the point of care lipid test market analysis from 2021 to 2031 to identify the prevailing point of care lipid test market opportunities.
  • The market research is offered along with information related to key drivers, restraints, and opportunities.
  • Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
  • In-depth analysis of the point of care lipid test market segmentation assists to determine the prevailing market opportunities.
  • Major countries in each region are mapped according to their revenue contribution to the global market.
  • Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
  • The report includes the analysis of the regional as well as global point of care lipid test market trends, key players, market segments, application areas, and market growth strategies.

Key Market Segments

By Product Type

  • Devices
  • Consumables

By Application

  • Endogenous Hyperlipemia
  • Combined hyperlipidemia
  • Familial Hypercholesterolemia
  • Others

By End User

  • Hospitals and Clinics
  • Diagnostic Laboratories
  • Others

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • Japan
    • China
    • India
    • Australia
    • South Korea
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil
    • Saudi Arabia
    • South Africa
    • Rest of LAMEA
  • Key Market Players
    • Abbott Laboratories
    • Callegari
    • F. Hoffmann-La Roche Ltd.
    • Menarini Group
    • Mico Bio Med
    • Nova Biomedical Corporation
    • SD Biosensor, Inc.
    • Sinocare Inc.
    • VivaChek Biotech (Hangzhou) Co.,Ltd 
    • Zoetis Inc.

TABLE OF CONTENTS

CHAPTER 1:INTRODUCTION

  • 1.1.Report description
  • 1.2.Key market segments
  • 1.3.Key benefits to the stakeholders
  • 1.4.Research Methodology
    • 1.4.1.Secondary research
    • 1.4.2.Primary research
    • 1.4.3.Analyst tools and models

CHAPTER 2:EXECUTIVE SUMMARY

  • 2.1.Key findings of the study
  • 2.2.CXO Perspective

CHAPTER 3:MARKET OVERVIEW

  • 3.1.Market definition and scope
  • 3.2.Key findings
    • 3.2.1.Top investment pockets
  • 3.3.Porter's five forces analysis
  • 3.4.Market dynamics
    • 3.4.1.Drivers
      • 3.4.1.1. Surge in obesity in populace
      • 3.4.1.2. Increase in government initiatives to promote healthy lifestyle
      • 3.4.1.3. Increase in prevalence of cardiovascular disease and diabetes
    • 3.4.2.Restraints
      • 3.4.2.1. High cost of product development
    • 3.4.3.Opportunities
      • 3.4.3.1. Growth potential of emerging economies
  • 3.5.COVID-19 Impact Analysis on the market

CHAPTER 4: POINT OF CARE LIPID TEST MARKET, BY PRODUCT TYPE

  • 4.1 Overview
    • 4.1.1 Market size and forecast
  • 4.2. Devices
    • 4.2.1 Key market trends, growth factors and opportunities
    • 4.2.2 Market size and forecast, by region
    • 4.2.3 Market share analysis by country
  • 4.3. Consumables
    • 4.3.1 Key market trends, growth factors and opportunities
    • 4.3.2 Market size and forecast, by region
    • 4.3.3 Market share analysis by country

CHAPTER 5: POINT OF CARE LIPID TEST MARKET, BY APPLICATION

  • 5.1 Overview
    • 5.1.1 Market size and forecast
  • 5.2. Endogenous Hyperlipemia
    • 5.2.1 Key market trends, growth factors and opportunities
    • 5.2.2 Market size and forecast, by region
    • 5.2.3 Market share analysis by country
  • 5.3. Combined hyperlipidemia
    • 5.3.1 Key market trends, growth factors and opportunities
    • 5.3.2 Market size and forecast, by region
    • 5.3.3 Market share analysis by country
  • 5.4. Familial Hypercholesterolemia
    • 5.4.1 Key market trends, growth factors and opportunities
    • 5.4.2 Market size and forecast, by region
    • 5.4.3 Market share analysis by country
  • 5.5. Others
    • 5.5.1 Key market trends, growth factors and opportunities
    • 5.5.2 Market size and forecast, by region
    • 5.5.3 Market share analysis by country

CHAPTER 6: POINT OF CARE LIPID TEST MARKET, BY END USER

  • 6.1 Overview
    • 6.1.1 Market size and forecast
  • 6.2. Hospitals and Clinics
    • 6.2.1 Key market trends, growth factors and opportunities
    • 6.2.2 Market size and forecast, by region
    • 6.2.3 Market share analysis by country
  • 6.3. Diagnostic Laboratories
    • 6.3.1 Key market trends, growth factors and opportunities
    • 6.3.2 Market size and forecast, by region
    • 6.3.3 Market share analysis by country
  • 6.4. Others
    • 6.4.1 Key market trends, growth factors and opportunities
    • 6.4.2 Market size and forecast, by region
    • 6.4.3 Market share analysis by country

CHAPTER 7: POINT OF CARE LIPID TEST MARKET, BY REGION

  • 7.1 Overview
    • 7.1.1 Market size and forecast
  • 7.2 North America
    • 7.2.1 Key trends and opportunities
    • 7.2.2 North America Market size and forecast, by Product Type
    • 7.2.3 North America Market size and forecast, by Application
    • 7.2.4 North America Market size and forecast, by End User
    • 7.2.5 North America Market size and forecast, by country
      • 7.2.5.1 U.S.
      • 7.2.5.1.1 Key market trends, growth factors and opportunities
      • 7.2.5.1.2 Market size and forecast, by Product Type
      • 7.2.5.1.3 Market size and forecast, by Application
      • 7.2.5.1.4 Market size and forecast, by End User
      • 7.2.5.2 Canada
      • 7.2.5.2.1 Key market trends, growth factors and opportunities
      • 7.2.5.2.2 Market size and forecast, by Product Type
      • 7.2.5.2.3 Market size and forecast, by Application
      • 7.2.5.2.4 Market size and forecast, by End User
      • 7.2.5.3 Mexico
      • 7.2.5.3.1 Key market trends, growth factors and opportunities
      • 7.2.5.3.2 Market size and forecast, by Product Type
      • 7.2.5.3.3 Market size and forecast, by Application
      • 7.2.5.3.4 Market size and forecast, by End User
  • 7.3 Europe
    • 7.3.1 Key trends and opportunities
    • 7.3.2 Europe Market size and forecast, by Product Type
    • 7.3.3 Europe Market size and forecast, by Application
    • 7.3.4 Europe Market size and forecast, by End User
    • 7.3.5 Europe Market size and forecast, by country
      • 7.3.5.1 Germany
      • 7.3.5.1.1 Key market trends, growth factors and opportunities
      • 7.3.5.1.2 Market size and forecast, by Product Type
      • 7.3.5.1.3 Market size and forecast, by Application
      • 7.3.5.1.4 Market size and forecast, by End User
      • 7.3.5.2 France
      • 7.3.5.2.1 Key market trends, growth factors and opportunities
      • 7.3.5.2.2 Market size and forecast, by Product Type
      • 7.3.5.2.3 Market size and forecast, by Application
      • 7.3.5.2.4 Market size and forecast, by End User
      • 7.3.5.3 UK
      • 7.3.5.3.1 Key market trends, growth factors and opportunities
      • 7.3.5.3.2 Market size and forecast, by Product Type
      • 7.3.5.3.3 Market size and forecast, by Application
      • 7.3.5.3.4 Market size and forecast, by End User
      • 7.3.5.4 Italy
      • 7.3.5.4.1 Key market trends, growth factors and opportunities
      • 7.3.5.4.2 Market size and forecast, by Product Type
      • 7.3.5.4.3 Market size and forecast, by Application
      • 7.3.5.4.4 Market size and forecast, by End User
      • 7.3.5.5 Spain
      • 7.3.5.5.1 Key market trends, growth factors and opportunities
      • 7.3.5.5.2 Market size and forecast, by Product Type
      • 7.3.5.5.3 Market size and forecast, by Application
      • 7.3.5.5.4 Market size and forecast, by End User
      • 7.3.5.6 Rest of Europe
      • 7.3.5.6.1 Key market trends, growth factors and opportunities
      • 7.3.5.6.2 Market size and forecast, by Product Type
      • 7.3.5.6.3 Market size and forecast, by Application
      • 7.3.5.6.4 Market size and forecast, by End User
  • 7.4 Asia-Pacific
    • 7.4.1 Key trends and opportunities
    • 7.4.2 Asia-Pacific Market size and forecast, by Product Type
    • 7.4.3 Asia-Pacific Market size and forecast, by Application
    • 7.4.4 Asia-Pacific Market size and forecast, by End User
    • 7.4.5 Asia-Pacific Market size and forecast, by country
      • 7.4.5.1 Japan
      • 7.4.5.1.1 Key market trends, growth factors and opportunities
      • 7.4.5.1.2 Market size and forecast, by Product Type
      • 7.4.5.1.3 Market size and forecast, by Application
      • 7.4.5.1.4 Market size and forecast, by End User
      • 7.4.5.2 China
      • 7.4.5.2.1 Key market trends, growth factors and opportunities
      • 7.4.5.2.2 Market size and forecast, by Product Type
      • 7.4.5.2.3 Market size and forecast, by Application
      • 7.4.5.2.4 Market size and forecast, by End User
      • 7.4.5.3 India
      • 7.4.5.3.1 Key market trends, growth factors and opportunities
      • 7.4.5.3.2 Market size and forecast, by Product Type
      • 7.4.5.3.3 Market size and forecast, by Application
      • 7.4.5.3.4 Market size and forecast, by End User
      • 7.4.5.4 Australia
      • 7.4.5.4.1 Key market trends, growth factors and opportunities
      • 7.4.5.4.2 Market size and forecast, by Product Type
      • 7.4.5.4.3 Market size and forecast, by Application
      • 7.4.5.4.4 Market size and forecast, by End User
      • 7.4.5.5 South Korea
      • 7.4.5.5.1 Key market trends, growth factors and opportunities
      • 7.4.5.5.2 Market size and forecast, by Product Type
      • 7.4.5.5.3 Market size and forecast, by Application
      • 7.4.5.5.4 Market size and forecast, by End User
      • 7.4.5.6 Rest of Asia-Pacific
      • 7.4.5.6.1 Key market trends, growth factors and opportunities
      • 7.4.5.6.2 Market size and forecast, by Product Type
      • 7.4.5.6.3 Market size and forecast, by Application
      • 7.4.5.6.4 Market size and forecast, by End User
  • 7.5 LAMEA
    • 7.5.1 Key trends and opportunities
    • 7.5.2 LAMEA Market size and forecast, by Product Type
    • 7.5.3 LAMEA Market size and forecast, by Application
    • 7.5.4 LAMEA Market size and forecast, by End User
    • 7.5.5 LAMEA Market size and forecast, by country
      • 7.5.5.1 Brazil
      • 7.5.5.1.1 Key market trends, growth factors and opportunities
      • 7.5.5.1.2 Market size and forecast, by Product Type
      • 7.5.5.1.3 Market size and forecast, by Application
      • 7.5.5.1.4 Market size and forecast, by End User
      • 7.5.5.2 Saudi Arabia
      • 7.5.5.2.1 Key market trends, growth factors and opportunities
      • 7.5.5.2.2 Market size and forecast, by Product Type
      • 7.5.5.2.3 Market size and forecast, by Application
      • 7.5.5.2.4 Market size and forecast, by End User
      • 7.5.5.3 South Africa
      • 7.5.5.3.1 Key market trends, growth factors and opportunities
      • 7.5.5.3.2 Market size and forecast, by Product Type
      • 7.5.5.3.3 Market size and forecast, by Application
      • 7.5.5.3.4 Market size and forecast, by End User
      • 7.5.5.4 Rest of LAMEA
      • 7.5.5.4.1 Key market trends, growth factors and opportunities
      • 7.5.5.4.2 Market size and forecast, by Product Type
      • 7.5.5.4.3 Market size and forecast, by Application
      • 7.5.5.4.4 Market size and forecast, by End User

CHAPTER 8: COMPETITIVE LANDSCAPE

  • 8.1. Introduction
  • 8.2. Top winning strategies
  • 8.3. Product Mapping of Top 10 Player
  • 8.4. Competitive Dashboard
  • 8.5. Competitive Heatmap
  • 8.6. Top player positioning, 2021

CHAPTER 9: COMPANY PROFILES

  • 9.1 Abbott Laboratories
    • 9.1.1 Company overview
    • 9.1.2 Key Executives
    • 9.1.3 Company snapshot
    • 9.1.4 Operating business segments
    • 9.1.5 Product portfolio
    • 9.1.6 Business performance
    • 9.1.7 Key strategic moves and developments
  • 9.2 Callegari
    • 9.2.1 Company overview
    • 9.2.2 Key Executives
    • 9.2.3 Company snapshot
    • 9.2.4 Operating business segments
    • 9.2.5 Product portfolio
    • 9.2.6 Business performance
    • 9.2.7 Key strategic moves and developments
  • 9.3 F. Hoffmann-La Roche Ltd.
    • 9.3.1 Company overview
    • 9.3.2 Key Executives
    • 9.3.3 Company snapshot
    • 9.3.4 Operating business segments
    • 9.3.5 Product portfolio
    • 9.3.6 Business performance
    • 9.3.7 Key strategic moves and developments
  • 9.4 Menarini Group
    • 9.4.1 Company overview
    • 9.4.2 Key Executives
    • 9.4.3 Company snapshot
    • 9.4.4 Operating business segments
    • 9.4.5 Product portfolio
    • 9.4.6 Business performance
    • 9.4.7 Key strategic moves and developments
  • 9.5 Mico Bio Med
    • 9.5.1 Company overview
    • 9.5.2 Key Executives
    • 9.5.3 Company snapshot
    • 9.5.4 Operating business segments
    • 9.5.5 Product portfolio
    • 9.5.6 Business performance
    • 9.5.7 Key strategic moves and developments
  • 9.6 Nova Biomedical Corporation
    • 9.6.1 Company overview
    • 9.6.2 Key Executives
    • 9.6.3 Company snapshot
    • 9.6.4 Operating business segments
    • 9.6.5 Product portfolio
    • 9.6.6 Business performance
    • 9.6.7 Key strategic moves and developments
  • 9.7 SD Biosensor, Inc.
    • 9.7.1 Company overview
    • 9.7.2 Key Executives
    • 9.7.3 Company snapshot
    • 9.7.4 Operating business segments
    • 9.7.5 Product portfolio
    • 9.7.6 Business performance
    • 9.7.7 Key strategic moves and developments
  • 9.8 Sinocare Inc.
    • 9.8.1 Company overview
    • 9.8.2 Key Executives
    • 9.8.3 Company snapshot
    • 9.8.4 Operating business segments
    • 9.8.5 Product portfolio
    • 9.8.6 Business performance
    • 9.8.7 Key strategic moves and developments
  • 9.9 VivaChek Biotech (Hangzhou) Co.,Ltd 
    • 9.9.1 Company overview
    • 9.9.2 Key Executives
    • 9.9.3 Company snapshot
    • 9.9.4 Operating business segments
    • 9.9.5 Product portfolio
    • 9.9.6 Business performance
    • 9.9.7 Key strategic moves and developments
  • 9.10 Zoetis Inc.
    • 9.10.1 Company overview
    • 9.10.2 Key Executives
    • 9.10.3 Company snapshot
    • 9.10.4 Operating business segments
    • 9.10.5 Product portfolio
    • 9.10.6 Business performance
    • 9.10.7 Key strategic moves and developments

LIST OF TABLES

  • TABLE 1. GLOBAL POINT OF CARE LIPID TEST MARKET, BY PRODUCT TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 2. POINT OF CARE LIPID TEST MARKET FOR DEVICES, BY REGION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 3. POINT OF CARE LIPID TEST MARKET FOR CONSUMABLES, BY REGION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 4. GLOBAL POINT OF CARE LIPID TEST MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 5. POINT OF CARE LIPID TEST MARKET FOR ENDOGENOUS HYPERLIPEMIA, BY REGION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 6. POINT OF CARE LIPID TEST MARKET FOR COMBINED HYPERLIPIDEMIA, BY REGION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 7. POINT OF CARE LIPID TEST MARKET FOR FAMILIAL HYPERCHOLESTEROLEMIA, BY REGION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 8. POINT OF CARE LIPID TEST MARKET FOR OTHERS, BY REGION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 9. GLOBAL POINT OF CARE LIPID TEST MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 10. POINT OF CARE LIPID TEST MARKET FOR HOSPITALS AND CLINICS, BY REGION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 11. POINT OF CARE LIPID TEST MARKET FOR DIAGNOSTIC LABORATORIES, BY REGION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 12. POINT OF CARE LIPID TEST MARKET FOR OTHERS, BY REGION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 13. POINT OF CARE LIPID TEST MARKET, BY REGION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 14. NORTH AMERICA POINT OF CARE LIPID TEST MARKET, BY PRODUCT TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 15. NORTH AMERICA POINT OF CARE LIPID TEST MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 16. NORTH AMERICA POINT OF CARE LIPID TEST MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 17. NORTH AMERICA POINT OF CARE LIPID TEST MARKET, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
  • TABLE 18. U.S. POINT OF CARE LIPID TEST MARKET, BY PRODUCT TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 19. U.S. POINT OF CARE LIPID TEST MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 20. U.S. POINT OF CARE LIPID TEST MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 21. CANADA POINT OF CARE LIPID TEST MARKET, BY PRODUCT TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 22. CANADA POINT OF CARE LIPID TEST MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 23. CANADA POINT OF CARE LIPID TEST MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 24. MEXICO POINT OF CARE LIPID TEST MARKET, BY PRODUCT TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 25. MEXICO POINT OF CARE LIPID TEST MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 26. MEXICO POINT OF CARE LIPID TEST MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 27. EUROPE POINT OF CARE LIPID TEST MARKET, BY PRODUCT TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 28. EUROPE POINT OF CARE LIPID TEST MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 29. EUROPE POINT OF CARE LIPID TEST MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 30. EUROPE POINT OF CARE LIPID TEST MARKET, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
  • TABLE 31. GERMANY POINT OF CARE LIPID TEST MARKET, BY PRODUCT TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 32. GERMANY POINT OF CARE LIPID TEST MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 33. GERMANY POINT OF CARE LIPID TEST MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 34. FRANCE POINT OF CARE LIPID TEST MARKET, BY PRODUCT TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 35. FRANCE POINT OF CARE LIPID TEST MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 36. FRANCE POINT OF CARE LIPID TEST MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 37. UK POINT OF CARE LIPID TEST MARKET, BY PRODUCT TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 38. UK POINT OF CARE LIPID TEST MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 39. UK POINT OF CARE LIPID TEST MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 40. ITALY POINT OF CARE LIPID TEST MARKET, BY PRODUCT TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 41. ITALY POINT OF CARE LIPID TEST MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 42. ITALY POINT OF CARE LIPID TEST MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 43. SPAIN POINT OF CARE LIPID TEST MARKET, BY PRODUCT TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 44. SPAIN POINT OF CARE LIPID TEST MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 45. SPAIN POINT OF CARE LIPID TEST MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 46. REST OF EUROPE POINT OF CARE LIPID TEST MARKET, BY PRODUCT TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 47. REST OF EUROPE POINT OF CARE LIPID TEST MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 48. REST OF EUROPE POINT OF CARE LIPID TEST MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 49. ASIA-PACIFIC POINT OF CARE LIPID TEST MARKET, BY PRODUCT TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 50. ASIA-PACIFIC POINT OF CARE LIPID TEST MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 51. ASIA-PACIFIC POINT OF CARE LIPID TEST MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 52. ASIA-PACIFIC POINT OF CARE LIPID TEST MARKET, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
  • TABLE 53. JAPAN POINT OF CARE LIPID TEST MARKET, BY PRODUCT TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 54. JAPAN POINT OF CARE LIPID TEST MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 55. JAPAN POINT OF CARE LIPID TEST MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 56. CHINA POINT OF CARE LIPID TEST MARKET, BY PRODUCT TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 57. CHINA POINT OF CARE LIPID TEST MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 58. CHINA POINT OF CARE LIPID TEST MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 59. INDIA POINT OF CARE LIPID TEST MARKET, BY PRODUCT TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 60. INDIA POINT OF CARE LIPID TEST MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 61. INDIA POINT OF CARE LIPID TEST MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 62. AUSTRALIA POINT OF CARE LIPID TEST MARKET, BY PRODUCT TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 63. AUSTRALIA POINT OF CARE LIPID TEST MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 64. AUSTRALIA POINT OF CARE LIPID TEST MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 65. SOUTH KOREA POINT OF CARE LIPID TEST MARKET, BY PRODUCT TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 66. SOUTH KOREA POINT OF CARE LIPID TEST MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 67. SOUTH KOREA POINT OF CARE LIPID TEST MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 68. REST OF ASIA-PACIFIC POINT OF CARE LIPID TEST MARKET, BY PRODUCT TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 69. REST OF ASIA-PACIFIC POINT OF CARE LIPID TEST MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 70. REST OF ASIA-PACIFIC POINT OF CARE LIPID TEST MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 71. LAMEA POINT OF CARE LIPID TEST MARKET, BY PRODUCT TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 72. LAMEA POINT OF CARE LIPID TEST MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 73. LAMEA POINT OF CARE LIPID TEST MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 74. LAMEA POINT OF CARE LIPID TEST MARKET, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
  • TABLE 75. BRAZIL POINT OF CARE LIPID TEST MARKET, BY PRODUCT TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 76. BRAZIL POINT OF CARE LIPID TEST MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 77. BRAZIL POINT OF CARE LIPID TEST MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 78. SAUDI ARABIA POINT OF CARE LIPID TEST MARKET, BY PRODUCT TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 79. SAUDI ARABIA POINT OF CARE LIPID TEST MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 80. SAUDI ARABIA POINT OF CARE LIPID TEST MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 81. SOUTH AFRICA POINT OF CARE LIPID TEST MARKET, BY PRODUCT TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 82. SOUTH AFRICA POINT OF CARE LIPID TEST MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 83. SOUTH AFRICA POINT OF CARE LIPID TEST MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 84. REST OF LAMEA POINT OF CARE LIPID TEST MARKET, BY PRODUCT TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 85. REST OF LAMEA POINT OF CARE LIPID TEST MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 86. REST OF LAMEA POINT OF CARE LIPID TEST MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 87. ABBOTT LABORATORIES: KEY EXECUTIVES
  • TABLE 88. ABBOTT LABORATORIES: COMPANY SNAPSHOT
  • TABLE 89. ABBOTT LABORATORIES: OPERATING SEGMENTS
  • TABLE 90. ABBOTT LABORATORIES: PRODUCT PORTFOLIO
  • TABLE 91. ABBOTT LABORATORIES: NET SALES
  • TABLE 92. ABBOTT LABORATORIES: KEY STRATERGIES
  • TABLE 93. CALLEGARI: KEY EXECUTIVES
  • TABLE 94. CALLEGARI: COMPANY SNAPSHOT
  • TABLE 95. CALLEGARI: OPERATING SEGMENTS
  • TABLE 96. CALLEGARI: PRODUCT PORTFOLIO
  • TABLE 97. CALLEGARI: NET SALES
  • TABLE 98. CALLEGARI: KEY STRATERGIES
  • TABLE 99. F. HOFFMANN-LA ROCHE LTD.: KEY EXECUTIVES
  • TABLE 100. F. HOFFMANN-LA ROCHE LTD.: COMPANY SNAPSHOT
  • TABLE 101. F. HOFFMANN-LA ROCHE LTD.: OPERATING SEGMENTS
  • TABLE 102. F. HOFFMANN-LA ROCHE LTD.: PRODUCT PORTFOLIO
  • TABLE 103. F. HOFFMANN-LA ROCHE LTD.: NET SALES
  • TABLE 104. F. HOFFMANN-LA ROCHE LTD.: KEY STRATERGIES
  • TABLE 105. MENARINI GROUP: KEY EXECUTIVES
  • TABLE 106. MENARINI GROUP: COMPANY SNAPSHOT
  • TABLE 107. MENARINI GROUP: OPERATING SEGMENTS
  • TABLE 108. MENARINI GROUP: PRODUCT PORTFOLIO
  • TABLE 109. MENARINI GROUP: NET SALES
  • TABLE 110. MENARINI GROUP: KEY STRATERGIES
  • TABLE 111. MICO BIO MED: KEY EXECUTIVES
  • TABLE 112. MICO BIO MED: COMPANY SNAPSHOT
  • TABLE 113. MICO BIO MED: OPERATING SEGMENTS
  • TABLE 114. MICO BIO MED: PRODUCT PORTFOLIO
  • TABLE 115. MICO BIO MED: NET SALES
  • TABLE 116. MICO BIO MED: KEY STRATERGIES
  • TABLE 117. NOVA BIOMEDICAL CORPORATION: KEY EXECUTIVES
  • TABLE 118. NOVA BIOMEDICAL CORPORATION: COMPANY SNAPSHOT
  • TABLE 119. NOVA BIOMEDICAL CORPORATION: OPERATING SEGMENTS
  • TABLE 120. NOVA BIOMEDICAL CORPORATION: PRODUCT PORTFOLIO
  • TABLE 121. NOVA BIOMEDICAL CORPORATION: NET SALES
  • TABLE 122. NOVA BIOMEDICAL CORPORATION: KEY STRATERGIES
  • TABLE 123. SD BIOSENSOR, INC.: KEY EXECUTIVES
  • TABLE 124. SD BIOSENSOR, INC.: COMPANY SNAPSHOT
  • TABLE 125. SD BIOSENSOR, INC.: OPERATING SEGMENTS
  • TABLE 126. SD BIOSENSOR, INC.: PRODUCT PORTFOLIO
  • TABLE 127. SD BIOSENSOR, INC.: NET SALES
  • TABLE 128. SD BIOSENSOR, INC.: KEY STRATERGIES
  • TABLE 129. SINOCARE INC.: KEY EXECUTIVES
  • TABLE 130. SINOCARE INC.: COMPANY SNAPSHOT
  • TABLE 131. SINOCARE INC.: OPERATING SEGMENTS
  • TABLE 132. SINOCARE INC.: PRODUCT PORTFOLIO
  • TABLE 133. SINOCARE INC.: NET SALES
  • TABLE 134. SINOCARE INC.: KEY STRATERGIES
  • TABLE 135. VIVACHEK BIOTECH (HANGZHOU) CO.,LTD : KEY EXECUTIVES
  • TABLE 136. VIVACHEK BIOTECH (HANGZHOU) CO.,LTD : COMPANY SNAPSHOT
  • TABLE 137. VIVACHEK BIOTECH (HANGZHOU) CO.,LTD : OPERATING SEGMENTS
  • TABLE 138. VIVACHEK BIOTECH (HANGZHOU) CO.,LTD : PRODUCT PORTFOLIO
  • TABLE 139. VIVACHEK BIOTECH (HANGZHOU) CO.,LTD : NET SALES
  • TABLE 140. VIVACHEK BIOTECH (HANGZHOU) CO.,LTD : KEY STRATERGIES
  • TABLE 141. ZOETIS INC.: KEY EXECUTIVES
  • TABLE 142. ZOETIS INC.: COMPANY SNAPSHOT
  • TABLE 143. ZOETIS INC.: OPERATING SEGMENTS
  • TABLE 144. ZOETIS INC.: PRODUCT PORTFOLIO
  • TABLE 145. ZOETIS INC.: NET SALES
  • TABLE 146. ZOETIS INC.: KEY STRATERGIES

LIST OF FIGURES

  • FIGURE 1. SEGMENTATION OF POINT OF CARE LIPID TEST MARKET,2021-2031
  • FIGURE 2. POINT OF CARE LIPID TEST MARKET,2021-2031
  • FIGURE 3. TOP INVESTMENT POCKETS, BY REGION
  • FIGURE 4. PORTER FIVE-1
  • FIGURE 5. PORTER FIVE-2
  • FIGURE 6. PORTER FIVE-3
  • FIGURE 7. PORTER FIVE-4
  • FIGURE 8. PORTER FIVE-5
  • FIGURE 9. POINT OF CARE LIPID TEST MARKET:DRIVERS, RESTRAINTS AND OPPORTUNITIES
  • FIGURE 10. POINT OF CARE LIPID TEST MARKET,BY PRODUCT TYPE,2021(%)
  • FIGURE 11. COMPARATIVE SHARE ANALYSIS OF DEVICES POINT OF CARE LIPID TEST MARKET, 2021 AND 2031(%)
  • FIGURE 12. COMPARATIVE SHARE ANALYSIS OF CONSUMABLES POINT OF CARE LIPID TEST MARKET, 2021 AND 2031(%)
  • FIGURE 13. POINT OF CARE LIPID TEST MARKET,BY APPLICATION,2021(%)
  • FIGURE 14. COMPARATIVE SHARE ANALYSIS OF ENDOGENOUS HYPERLIPEMIA POINT OF CARE LIPID TEST MARKET, 2021 AND 2031(%)
  • FIGURE 15. COMPARATIVE SHARE ANALYSIS OF COMBINED HYPERLIPIDEMIA POINT OF CARE LIPID TEST MARKET, 2021 AND 2031(%)
  • FIGURE 16. COMPARATIVE SHARE ANALYSIS OF FAMILIAL HYPERCHOLESTEROLEMIA POINT OF CARE LIPID TEST MARKET, 2021 AND 2031(%)
  • FIGURE 17. COMPARATIVE SHARE ANALYSIS OF OTHERS POINT OF CARE LIPID TEST MARKET, 2021 AND 2031(%)
  • FIGURE 18. POINT OF CARE LIPID TEST MARKET,BY END USER,2021(%)
  • FIGURE 19. COMPARATIVE SHARE ANALYSIS OF HOSPITALS AND CLINICS POINT OF CARE LIPID TEST MARKET, 2021 AND 2031(%)
  • FIGURE 20. COMPARATIVE SHARE ANALYSIS OF DIAGNOSTIC LABORATORIES POINT OF CARE LIPID TEST MARKET, 2021 AND 2031(%)
  • FIGURE 21. COMPARATIVE SHARE ANALYSIS OF OTHERS POINT OF CARE LIPID TEST MARKET, 2021 AND 2031(%)
  • FIGURE 22. POINT OF CARE LIPID TEST MARKET BY REGION,2021
  • FIGURE 23. U.S. POINT OF CARE LIPID TEST MARKET,2021-2031($MILLION)
  • FIGURE 24. CANADA POINT OF CARE LIPID TEST MARKET,2021-2031($MILLION)
  • FIGURE 25. MEXICO POINT OF CARE LIPID TEST MARKET,2021-2031($MILLION)
  • FIGURE 26. GERMANY POINT OF CARE LIPID TEST MARKET,2021-2031($MILLION)
  • FIGURE 27. FRANCE POINT OF CARE LIPID TEST MARKET,2021-2031($MILLION)
  • FIGURE 28. UK POINT OF CARE LIPID TEST MARKET,2021-2031($MILLION)
  • FIGURE 29. ITALY POINT OF CARE LIPID TEST MARKET,2021-2031($MILLION)
  • FIGURE 30. SPAIN POINT OF CARE LIPID TEST MARKET,2021-2031($MILLION)
  • FIGURE 31. REST OF EUROPE POINT OF CARE LIPID TEST MARKET,2021-2031($MILLION)
  • FIGURE 32. JAPAN POINT OF CARE LIPID TEST MARKET,2021-2031($MILLION)
  • FIGURE 33. CHINA POINT OF CARE LIPID TEST MARKET,2021-2031($MILLION)
  • FIGURE 34. INDIA POINT OF CARE LIPID TEST MARKET,2021-2031($MILLION)
  • FIGURE 35. AUSTRALIA POINT OF CARE LIPID TEST MARKET,2021-2031($MILLION)
  • FIGURE 36. SOUTH KOREA POINT OF CARE LIPID TEST MARKET,2021-2031($MILLION)
  • FIGURE 37. REST OF ASIA-PACIFIC POINT OF CARE LIPID TEST MARKET,2021-2031($MILLION)
  • FIGURE 38. BRAZIL POINT OF CARE LIPID TEST MARKET,2021-2031($MILLION)
  • FIGURE 39. SAUDI ARABIA POINT OF CARE LIPID TEST MARKET,2021-2031($MILLION)
  • FIGURE 40. SOUTH AFRICA POINT OF CARE LIPID TEST MARKET,2021-2031($MILLION)
  • FIGURE 41. REST OF LAMEA POINT OF CARE LIPID TEST MARKET,2021-2031($MILLION)
  • FIGURE 42. TOP WINNING STRATEGIES, BY YEAR
  • FIGURE 43. TOP WINNING STRATEGIES, BY DEVELOPMENT
  • FIGURE 44. TOP WINNING STRATEGIES, BY COMPANY
  • FIGURE 45. PRODUCT MAPPING OF TOP 10 PLAYERS
  • FIGURE 46. COMPETITIVE DASHBOARD
  • FIGURE 47. COMPETITIVE HEATMAP OF TOP 10 KEY PLAYERS
  • FIGURE 48. TOP PLAYER POSITIONING, 2021
  • FIGURE 49. ABBOTT LABORATORIES.: NET SALES ($MILLION)
  • FIGURE 50. CALLEGARI.: NET SALES ($MILLION)
  • FIGURE 51. F. HOFFMANN-LA ROCHE LTD..: NET SALES ($MILLION)
  • FIGURE 52. MENARINI GROUP.: NET SALES ($MILLION)
  • FIGURE 53. MICO BIO MED.: NET SALES ($MILLION)
  • FIGURE 54. NOVA BIOMEDICAL CORPORATION.: NET SALES ($MILLION)
  • FIGURE 55. SD BIOSENSOR, INC..: NET SALES ($MILLION)
  • FIGURE 56. SINOCARE INC..: NET SALES ($MILLION)
  • FIGURE 57. VIVACHEK BIOTECH (HANGZHOU) CO.,LTD .: NET SALES ($MILLION)
  • FIGURE 58. ZOETIS INC..: NET SALES ($MILLION)